Uniphar plc (UPR)
LSE
Closed
Aug 24, 2026
Day's Range
359.8652 wk Range
294.00Overview - UPR - Uniphar plc
Key Statistics
Valuation
Enterprise Value
1.26B
P/E (Trailing)
‪21.17‬
P/E (Forward)
‪15.23‬
PEG Ratio
‪15.23‬
Price / Sales (TTM)
‪0.31‬
Price / Book
‪265.51‬
EV / EBITDA
‪11.76‬
Profitability
Profit Margin
‪1.66%‬
Operating Margin
‪3.33%‬
Return on Assets
‪3.63%‬
Return on Equity
‪12.67%‬
Ownership
Shares Outstanding
259.57M
Float
233.75M
Held by Insiders
‪5.52%‬
Held by Institutions
‪50.24%‬
Price stats
Beta
‪1.10‬
50-Day Avg
‪4.49‬
200-Day Avg
‪4.13‬
Dividends
Payout Ratio
‪10.05%‬
Frequency
Semi-Annual
Analyst Consensus
3 analysts
Average price target
‪€ 419.40‬Market Cap - UPR - Uniphar plc
Peers - UPR - Uniphar plc
Peer Comparison
Compared with companies in Medical Distribution listed on LSE.
Profile Summary - UPR - Uniphar plc
About
Uniphar plc is a diversified healthcare-based services provider headquartered in Ireland. The primary function of Uniphar is to deliver integrated services across the pharmaceutical and healthcare sectors, facilitating efficient operations within these industries. Uniphar plays a crucial role in connecting healthcare…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
